Scientific Online Resource System

Actual Nephrology

The future of renal health: Biotechnological innovations and sustainable solutions

Rumina Koleva, Aleksandar Petrov, Miroslava Benkova - Petrova, Svetlana Staykova

Abstract

End-stage chronic kidney disease affects millions of patients worldwide and places a significant burden on both healthcare systems and the environment. Traditional hemodialysis is associated with high consumption of water, energy, and the generation of waste. In contrast, modern biotechnological solutions—including portable and implantable bioartificial kidneys as well as 3D bioprinting of renal tissues—offer a novel approach for renal replacement therapy. These technologies have the potential to significantly improve patients’ quality of life while reducing the environmental impact of treatment. This systematic review analyzes data from clinical trials and experimental models, evaluating the functionality, resource efficiency, and ecological benefits of the biomaterials used. The findings indicate that portable systems provide stable filtration with minimal resource expenditure, implantable devices demonstrate sustained renal function without frequent interventions, and 3D bioprinting facilitates the creation of microarchitectural tissues with optimal cellular integration. Collectively, these innovations may transform nephrological practice by delivering more effective treatment with a lower environmental footprint.


Keywords

kidney health, biotechnology, bioartificial kidneys, portable dialysis devices, implantable bioreactor, 3D bioprinting, regenerative medicine, environmental sustainability, biodegradable biomaterials, carbon footprint

Full Text


References

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011 Dec;80(12):1258-70. doi: 10.1038/ki.2011.368. Epub 2011 Oct 12. PMID: 21993585.

Fransen MFJ, Addario G, Bouten CVC, Halary F, Moroni L, Mota C. Bioprinting of kidney in vitro models: cells, biomaterials, and manufacturing techniques. Essays Biochem. 2021 Aug 10;65(3):587-602. doi: 10.1042/EBC20200158. PMID: 34096573; PMCID: PMC8365327.

Kim EJ, Chen C, Gologorsky R, Santandreu A, Torres A, Wright N, et al. Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes. Nat Commun. 2023;14(1):4890. doi: 10.1038/s41467-023-19820-8. PMID: 37644033.

Lima F, Pizzo A, Olivari F, Giordana G. Sustainability and dialysis: The 4 main points for a green dialysis. Giornale di Clinica Nefrologica e Dialisi. 2024;36(1):72-82. doi: 10.33393/gcnd.2024.3127.

Luminary Labs (KidneyX Sustainability Prize). 7 solutions to make kidney care more sustainable [Internet]. KidneyX Sustainability Prize Winners Announcement. 2023 [цитиран 2025 Мар 05]. Наличен от: https://www.luminary-labs.com/7-solutions-to-make-kidney-care-more-sustainable/

Ramada DJL, de Vries JC, Vollenbroek JC, Noor N, ter Beek O, Mihăilă SM, Wieringa FP, Masereeuw R, Gerritsen KG, Stamatialis D. Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges. Nat Rev Nephrol. 2023 Aug;19(8):481-490. doi: 10.1038/s41581-023-00726-9. Epub 2023 Jun 5. PMID: 37277461; PMCID: PMC10240485.

Sehgal AR, Slutzman JE, Huml AM. Sources of variation in the carbon footprint of hemodialysis treatment. J Am Soc Nephrol. 2022 Jun;33(6):1790-1795. doi: 10.1681/ASN.2022010086. PMID: 35654600; PMCID: PMC9529184.

Turunen S, Kaisto S, Skovorodkin I, Mironov V, Kalpio T, Vainio S, Rak-Raszewska A. 3D bioprinting of the kidney – hype or hope? AIMS Cell Tissue Eng. 2018;2(3):119-162. doi: 10.3934/celltissue.2018.3.119.




DOI: http://dx.doi.org/10.14748/an.v19i1.10328

Refbacks

About The Authors

Rumina Koleva
Clinic of Nephrology, St. Marina University Hospital, Varna TS Nephrology, Hemodialysis, and Toxicology, Second Department of Internal Diseases, Faculty of Medicine, Medical University of Varna
Bulgaria

Aleksandar Petrov
Clinic of Nephrology, St. Marina University Hospital, Varna TS Nephrology, Hemodialysis, and Toxicology, Second Department of Internal Diseases, Faculty of Medicine, Medical University of Varna
Bulgaria

Miroslava Benkova - Petrova
Clinic of Nephrology, St. Marina University Hospital, Varna TS Nephrology, Hemodialysis, and Toxicology, Second Department of Internal Diseases, Faculty of Medicine, Medical University of Varna
Bulgaria

Svetlana Staykova
Clinic of Nephrology, St. Marina University Hospital, Varna TS Nephrology, Hemodialysis, and Toxicology, Second Department of Internal Diseases, Faculty of Medicine, Medical University of Varna
Bulgaria

Font Size


|